Cloudbreak Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	40.15	34.86	52.65	15.92
Short-Term Investments	-	-	7.5	63.19
Trading Asset Securities	18.2	-	-	-
Cash & Short-Term Investments	58.35	34.86	60.15	79.11
Cash Growth	67.38%	-42.05%	-23.96%	-
Other Receivables	2.43	2.09	0.77	0.81
Receivables	2.43	2.09	0.77	0.81
Inventory	0.11	-	-	-
Prepaid Expenses	3.38	0.05	0.17	0.18
Other Current Assets	0.06	0.51	0.37	0.01
Total Current Assets	64.34	37.51	61.47	80.11
Property, Plant & Equipment	2.22	2.43	3.27	1.17
Other Long-Term Assets	0.04	0.07	0.1	0.81
Total Assets	66.61	40.01	64.83	82.09
Accounts Payable	0.84	1.76	2.1	1.23
Accrued Expenses	4.48	2.06	1.72	1.85
Short-Term Debt	0.44	386.2	322.46	109.96
Current Portion of Leases	0.22	0.3	0.32	0.29
Current Income Taxes Payable	0.04	0.08	0.02	-
Other Current Liabilities	-	0.95	0.78	113.38
Total Current Liabilities	6.02	391.35	327.4	226.7
Long-Term Leases	0.1	0.21	0.23	0.55
Total Liabilities	6.12	391.56	327.63	227.25
Common Stock	0.08	0.05	0.05	0.05
Additional Paid-In Capital	686.29	258.28	258.28	258.28
Retained Earnings	-411.91	-344.25	-245.12	-115.7
Comprehensive Income & Other	-213.97	-265.62	-276	-287.79
Shareholders' Equity	60.49	-351.55	-262.79	-145.16
Total Liabilities & Equity	66.61	40.01	64.83	82.09
Total Debt	0.76	386.71	323	110.8
Net Cash (Debt)	57.59	-351.84	-262.85	-31.69
Net Cash Per Share	0.09	-0.74	-0.57	-0.07
Filing Date Shares Outstanding	844.57	475.39	462.54	458.6
Total Common Shares Outstanding	844.57	475.39	462.54	458.6
Working Capital	58.32	-353.84	-265.93	-146.59
Book Value Per Share	0.07	-0.74	-0.57	-0.32
Tangible Book Value	60.49	-351.55	-262.79	-145.16
Tangible Book Value Per Share	0.07	-0.74	-0.57	-0.32
Machinery	0.98	0.84	0.75	0.36
Leasehold Improvements	1.05	1.04	1.01	0.16